Jamaican (JSE) Healthcare Services Industry Analysis

Industry Valuation and Performance

Has the Jamaican Healthcare Services Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Fri, 21 Aug 2026	JA$6.7b	JA$9.3b	JA$44.6m	24x	149.8x	0.7x
Sun, 19 Jul 2026	JA$6.9b	JA$9.2b	JA$56.1m	25.9x	122.2x	0.7x
Tue, 16 Jun 2026	JA$6.1b	JA$9.1b	JA$27.6m	24x	222.7x	0.7x
Thu, 14 May 2026	JA$6.6b	JA$9.1b	JA$29.0m	25x	226.9x	0.7x
Sat, 11 Apr 2026	JA$6.7b	JA$9.1b	JA$15.7m	27.5x	425.5x	0.7x
Mon, 09 Mar 2026	JA$6.8b	JA$9.0b	JA$48.8m	20.6x	139.4x	0.8x
Wed, 04 Feb 2026	JA$6.8b	JA$9.1b	JA$56.3m	19.5x	120.1x	0.7x
Fri, 02 Jan 2026	JA$7.0b	JA$9.1b	JA$65.9m	21.7x	106.7x	0.8x
Sun, 30 Nov 2025	JA$7.0b	JA$9.0b	JA$149.2m	19.6x	47.2x	0.8x
Tue, 28 Oct 2025	JA$7.5b	JA$8.9b	JA$92.7m	22.2x	81.4x	0.8x
Thu, 25 Sep 2025	JA$7.5b	JA$8.9b	JA$57.6m	35.1x	130.5x	0.8x
Sat, 23 Aug 2025	JA$7.7b	JA$8.9b	JA$95.1m	25.1x	80.9x	0.9x
Mon, 21 Jul 2025	JA$2.7b	JA$6.5b	-JA$147,247,568.00	42.5x	-18.4x	0.4x
Wed, 18 Jun 2025	JA$2.6b	JA$6.5b	-JA$165,698,977.00	27.1x	-15.7x	0.4x
Fri, 16 May 2025	JA$7.9b	JA$8.6b	JA$30.2m	23.2x	260.5x	0.9x
Sun, 13 Apr 2025	JA$8.1b	JA$8.7b	JA$75.6m	17x	106.8x	0.9x
Tue, 11 Mar 2025	JA$8.3b	JA$8.6b	JA$109.3m	21x	76x	1x
Thu, 06 Feb 2025	JA$9.2b	JA$8.4b	JA$76.3m	25.5x	121x	1.1x
Sat, 04 Jan 2025	JA$10.0b	JA$8.5b	JA$111.5m	27.5x	89.2x	1.2x
Mon, 02 Dec 2024	JA$9.5b	JA$8.7b	JA$149.0m	19.7x	63.5x	1.1x
Wed, 30 Oct 2024	JA$9.5b	JA$8.7b	JA$147.7m	19.6x	64.6x	1.1x
Fri, 27 Sep 2024	JA$9.6b	JA$8.7b	JA$207.3m	19.4x	46.4x	1.1x
Sun, 25 Aug 2024	JA$6.8b	JA$7.2b	JA$165.5m	12.9x	41x	0.9x
Tue, 23 Jul 2024	JA$7.1b	JA$7.1b	JA$139.1m	12.9x	50.9x	1x
Thu, 20 Jun 2024	JA$7.4b	JA$7.0b	JA$366.8m	47.8x	20x	1.1x
Sat, 18 May 2024	JA$7.6b	JA$6.9b	JA$400.6m	90.6x	19x	1.1x
Mon, 15 Apr 2024	JA$7.7b	JA$6.9b	JA$400.6m	85.9x	19.1x	1.1x
Wed, 13 Mar 2024	JA$7.8b	JA$6.9b	JA$397.2m	89x	19.6x	1.1x
Fri, 09 Feb 2024	JA$7.9b	JA$6.9b	JA$456.4m	17.5x	17.3x	1.1x
Sun, 07 Jan 2024	JA$7.7b	JA$6.9b	JA$415.8m	16.8x	18.5x	1.1x
Tue, 05 Dec 2023	JA$8.4b	JA$6.8b	JA$411.7m	19.7x	20.5x	1.2x
Thu, 02 Nov 2023	JA$8.5b	JA$6.9b	JA$488.8m	18.7x	17.4x	1.2x
Sat, 30 Sep 2023	JA$8.5b	JA$6.9b	JA$492.8m	19.4x	17.3x	1.2x
Mon, 28 Aug 2023	JA$9.1b	JA$6.8b	JA$480.9m	21.4x	18.9x	1.3x

Current Industry PE

Investors are optimistic on the Jamaican Healthcare industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 148x which is higher than its 3-year average PE of 87.1x.

The industry is trading close to its 3-year average PS ratio of 0.94x.

Past Earnings Growth

The earnings for companies in the Healthcare industry have declined 55% per year over the last three years.
Meanwhile revenues for these companies have grown 11% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Jamaican Healthcare industry?


JM Market	-0.43%
Healthcare	-4.73%
Healthcare Services	-4.73%
Healthcare Services	-0.092%
Healthcare Facilities	-5.71%
Healthcare Distributors	-6.56%

Industry PE

Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 18.1x.

It looks like they are confident that earnings will grow faster in the future than they have historically.

Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Company	Last Price	7D	1Y	Valuation
IPCL Image Plus Consultants	JA$1.15	4.5% +JA$62.0m	19.8%	PE21x
RAWILL R.A. Williams Distributors	JA$0.40	8.1% +JA$60.0m	-11.1%	PE47.4x
INDIES Indies Pharma Jamaica	JA$2.73	1.1% +JA$40.0m	-15.7%	PE28.5x

Company

Last Price

Valuation

IPCL Image Plus Consultants

JA$1.15

4.5%
+JA$62.0m

19.8%

PE21x

RAWILL R.A. Williams Distributors

JA$0.40

8.1%
+JA$60.0m

-11.1%

PE47.4x

INDIES Indies Pharma Jamaica

JA$2.73

1.1%
+JA$40.0m

-15.7%

PE28.5x

New major risk - Revenue and earnings growth

Earnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.2% per year over the past 5 years. Minor Risks Dividend is not well covered by earnings (142% payout ratio). Profit margins are more than 30% lower than last year (12% net profit margin). Market cap is less than US$100m (JA$3.60b market cap, or US$22.8m).

Jamaican (JSE) Healthcare Services Industry Analysis

Industry Valuation and Performance

Industry Trends

Top Stock Gainers and Losers

Latest News

First quarter 2027 earnings released: EPS: JA$0.002 (vs JA$0.001 in 1Q 2026)

New major risk - Financial position

Investor sentiment improves as stock rises 16%

New minor risk - Profit margin trend

New major risk - Revenue and earnings growth

Less than half of directors are independent